Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials.

Shamabadi, Ahmad; Ahmadzade, Ali; Aqamolaei, Ali; Mortazavi, Seyyed Hosein; Hasanzadeh, Alireza; Akhondzadeh, Shahin

Shamabadi, Ahmad; Ahmadzade, Ali; Aqamolaei, Ali; Mortazavi, Seyyed Hosein; Hasanzadeh, Alireza; Akhondzadeh, Shahin.

Afiliación

Shamabadi A; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ahmadzade A; Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Aqamolaei A; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mortazavi SH; Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hasanzadeh A; Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Akhondzadeh S; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Iran J Psychiatry ; 17(3): 320-340, 2022 Jul.

Article en En | MEDLINE | ID: mdl-36474699

Palabras clave

Behavioral Symptoms; Depressive Disorder; Glutamate Receptor; Glutamates; Resistant Depression; Systematic Review; Treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Idioma: En Revista: Iran J Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google